QIF-T0120
mediumLatent cognitive decline via chronic electrode micromotion
Tier 5 — Theoretical (Modeled / Simulated)
Legacy status: THEORETICAL
Technique Details
- Tactic
- QIF-P.DS
- Status
- THEORETICAL
- Bands
- I0, N1, N2, N3, N4, N5, N6, N7
✚ Therapeutic Application
Chronic micromotion of implanted electrodes causing progressive gliosis, impedance drift, and degradation of neural recording/stimulation fidelity, leading to gradual cognitive decline
Clinical Analog
Chronic DBS electrode maintenance / impedance management
Treats
- DBS electrode revision
- chronic implant biocompatibility
- recording electrode longevity
Neural Impact
8 of 7 neural bands affected
Drag to rotate. Click a region to learn more.
Click or hover over a glowing region to see the attack techniques targeting it and their severity.
DSM-5-TR Diagnostic Mappings
Diagnostic category references for threat modeling, not diagnostic claims.
Pathway: I0 (electrode-tissue interface) → gliosis → impedance change → recording degradation → cognitive function decline
Following Poldrack (2006), brain region disruption does not uniquely predict psychiatric outcomes.
Scoring
NISS:1.1/BI:H/CR:N/CD:H/CV:E/RV:P/NP:P Governance
Neurorights at Risk
This technique threatens 3 of the 4 proposed neurorights (Ienca & Andorno, 2017).
FDORA §3305 Compliance
- ! CVSS cannot express neural-specific impacts
- ! Threat not yet in regulatory threat catalogs
Population Vulnerability
CRB vulnerability adjustment (γ=0.30) accounts for age, diagnosis severity, consent capacity, and device dependency.
| Population | NISS Base | Adjusted | Severity | Delta |
|---|---|---|---|---|
| Adult (Default) | 6.1 | 6.1 | Medium | - |
| Child (10yr) + ADHD | 6.1 | 7.2 | High ▲ | +1.08 |
| Adult with ALS | 6.1 | 7.1 | High ▲ | +0.98 |
Validation Status
Theoretical / Not yet validated. This technique has not been independently tested. See the validation dashboard for what has been tested.